Delivery Order SPE2DB24D2212-SPE2DB25FHQSR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of VIMPAT 100 mg tablets (60-count units) valued at $2,048.51. This firm fixed-price delivery order, which is expected to be completed by August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The Defense Logistics Agency awarded a $1,254.96 delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 200 mg, a pharmaceutical product used in neurological treatment. This contract, issued on July 14, 2025, with an ultimate completion date of July 15, 2025, is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,279.00 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of VIMPAT 10 mg/mL solution in 200mL quantities. This is a firm fixed price, non-set-aside contract with a completion date of June 6, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where...
- Amerisourcebergen Drug Corp has received a $4,661.28 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 4562756824 VIMPAT 150 MG TABLET 60S. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to the DLA by November 9, 2023 from its headquarters in Conshohocken, Pennsylvania. No set-aside designation was used for this award issued against an indefinite delivery contract held by Amerisourcebergen's Corporate Office division with the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 20, 2025, for VIMPAT 10 mg/mL solution in 200 mL quantities, with a ceiling value of $1,524.74. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 21, 2025. The contract is unset-aside and represents a child order under the company's larger Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide VIMPAT 100 MG TABLET 60S pharmaceutical products. The $2,384.84 contract has a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,301.65 firm fixed price delivery order is for the supply of VIMPAT 50 MG TABLET 60S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. This IDC serves as a primary vehicle for providing...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,598.25 firm fixed-price delivery order is for VIMPAT 200 MG TABLET UD 60S, a pharmaceutical product, with a period of performance through June 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- The Defense Logistics Agency awarded a $1,455.99 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for VIMPAT 10 mg/mL Solution in 200 mL quantities. This firm fixed price order, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was awarded without a set-aside designation through competitive procurement, and performance will occur at the...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,117.65 firm fixed-price contract is for the supply of VIMPAT 50 mg tablets. This order is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA, valued up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs and facilities worldwide. The...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHQSRDelivery Order
The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of VIMPAT 150 mg tablets (60 count) valued at $1,013.36. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle that extends through December 2026 and enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. The company's portfolio of federal contract awards demonstrates extensive capability in delivering both brand-name and generic medications across multiple therapeutic domains, including neurological treatments, diabetes medications, pain management pharmaceuticals, and specialized medical supplies. The SPE2DX indefinite delivery contract functions as a flexible global pharmaceutical support vehicle, positioning AmerisourceBergen to fulfill diverse medical supply requirements across the defense enterprise while the DLA Troop Support prepares to establish generation V contracts with multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/4/25 |